Has MRD monitoring superseded other prognostic factors in adult ALL?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Has MRD monitoring superseded other prognostic factors in adult ALL?
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 23, Pages 4470-4481
Publisher
American Society of Hematology
Online
2012-10-03
DOI
10.1182/blood-2012-06-379040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia
- (2012) G. Gaipa et al. HAEMATOLOGICA
- Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases
- (2012) J-Q Mi et al. LEUKEMIA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study
- (2011) R. Ben Abdelali et al. BLOOD
- CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
- (2011) F. Mannelli et al. HAEMATOLOGICA
- Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia
- (2011) Adele K. Fielding HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- (2011) A. K. Fielding Hematology-American Society of Hematology Education Program
- Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testing
- (2010) Elaine Coustan-Smith et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
- (2010) V. Conter et al. BLOOD
- New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice
- (2010) C. G. Mullighan CLINICAL CANCER RESEARCH
- Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
- (2010) S. Soverini et al. HAEMATOLOGICA
- Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
- (2010) Deborah A. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
- (2009) R. Bassan et al. BLOOD
- Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
- (2009) Bella Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2009) Seok Lee et al. CANCER
- Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia
- (2009) T. Burmeister et al. HAEMATOLOGICA
- Prognostic Implications ofNOTCH1andFBXW7Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol
- (2009) Marc R. Mansour et al. JOURNAL OF CLINICAL ONCOLOGY
- IKZF1(Ikaros) Deletions inBCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report
- (2009) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
- (2009) Françoise Huguet et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
- (2009) V H J Van der Velden et al. LEUKEMIA
- Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
- (2009) M Brüggemann et al. LEUKEMIA
- Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry
- (2009) Ester Mejstříková et al. PEDIATRIC BLOOD & CANCER
- CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy
- (2008) M. N. Dworzak et al. BLOOD
- NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
- (2008) V. Asnafi et al. BLOOD
- Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia
- (2008) D. A. Thomas et al. BLOOD
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- (2008) W. Stock et al. BLOOD
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
- (2008) M. J. Borowitz et al. BLOOD
- B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
- (2008) E Fronkova et al. BONE MARROW TRANSPLANTATION
- Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study
- (2008) Jerzy Holowiecki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Generation of flow cytometry data files with a potentially infinite number of dimensions
- (2008) Carlos E. Pedreira et al. CYTOMETRY PART A
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started